17-Hydroxyprogesterone (17-OHP)

The ranges shown for adult men and women above are the everyday reference figures. The numbers that decide whether this is congenital adrenal hyperplasia are different, and they are the part most consumer pages skip: they quote a single normal range, flag anything above it as "abnormal," and stop. The real diagnostic ladder has three rungs, and the middle rung is where almost everyone with a mildly raised result lands. A reading of, say, 300 is not a diagnosis but an instruction to test further.

The serious end of the scale is congenital adrenal hyperplasia, which comes in two forms. Classic CAH is severe, shows up at birth, and can be life-threatening if untreated, which is why 17-OHP is part of routine newborn screening in the United States (most accurate more than 24 hours after birth). Nonclassic, or mild, CAH surfaces later, from early childhood to early adulthood, and announces itself through signs of androgen excess rather than a crisis.

That androgen-excess piece explains why a backed-up precursor causes anything at all. When 21-hydroxylase is blocked, the steroids that can't move toward cortisol get shunted toward androgen production instead, so the body makes more male-pattern hormone than it should. In practice that looks like irregular periods, excess body hair, and acne, the cluster that sends many people to get tested. A slightly elevated 17-OHP in a female with those symptoms is one of the most common ways this number turns up.

Here is the catch that makes 17-OHP a famously misread number: a modest elevation is not unique to CAH. Polycystic ovary syndrome, ovarian and adrenal tumors, and nonclassic CAH can all raise it. PCOS in particular overlaps so heavily with nonclassic CAH that the two cannot be told apart by appearance. A slightly high 17-OHP in a woman with irregular cycles and acne is genuinely ambiguous, and treating it as a verdict is how the wrong diagnosis gets made.

This is also why the gray zone matters. A baseline between 200 and 1000 ng/dL doesn't tell you which of these is in play; it tells you the single test has run out of resolution. Comparing 17-OHP against markers like androstenedione and testosterone maps how far the shunt toward androgens has gone, while cortisol shows whether the product the precursor was meant to become is actually low.

Before anyone reads a 17-OHP as a diagnosis, the sample has to have been drawn correctly, because this hormone is unusually sensitive to timing. It follows a circadian rhythm: highest in the early morning, falling through the day. An afternoon sample can read falsely reassuring, or, layered with cycle timing, falsely high. Guidelines are specific that the draw should happen in the early morning, roughly 7 to 9 a.m.

There is a second timing trap for menstruating women: 17-OHP rises after ovulation, so a luteal-phase sample can read elevated for reasons that have nothing to do with any enzyme. The fix is to draw in the early follicular phase, in the first days of the cycle.

The stimulation test is where the floodgate gets tested under pressure. A measured dose of synthetic ACTH prods the adrenal glands, and 17-OHP is checked again 60 minutes later. If the precursor really is dammed behind a deficient enzyme, that push makes it surge: a stimulated peak above about 1000 ng/dL (30 nmol/L) confirms nonclassic CAH. Since ACTH is the upstream signal that turns the adrenal glands on, measuring 17-OHP after an ACTH challenge is the cleanest way to see whether the gate holds, which is why a doctor may ask for it even when the baseline looks only modestly high.

17-OHP rarely travels alone. It is usually read with the rest of the adrenal and androgen picture in a broader hormone panel, where the precursor's level only makes sense next to the androgens it can be shunted into and the cortisol it was meant to become. Markers like DHEA-S round out where the adrenal output is going. To read the whole set at once, the guide to reading a hormone panel walks through how the pieces fit.

One last point about a number this timing-sensitive: a snapshot of a hormone that swings with the hour and the cycle is easy to over-read. Because the morning peak and the follicular-phase window decide so much of what the figure means, getting the timing of the draw right matters more here than for almost any other hormone. What 17-OHP does well is point at one specific gate. Whether that gate is truly stuck is a question for your doctor and, often, a second test.